3-(((tert-Butoxycarbonyl)amino)methyl)-1,2,4-oxadiazole-5-carboxylic acid

Catalog No. :
ACBYPB231
CAS No. :
946667-81-8
Molecular Formula :
C9H13N3O5
Molecular Weight :
243.22

IUPAC Name:3-(((tert-Butoxycarbonyl)amino)methyl)-1,2,4-oxadiazole-5-carboxylic acid

3-(((tert-Butoxycarbonyl)amino)methyl)-1,2,4-oxadiazole-5-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$258.00Login to see priceInquiryInquiry
1g97%$646.00Login to see priceInquiryInquiry
5g97%$1940.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(((tert-Butoxycarbonyl)amino)methyl)-1,2,4-oxadiazole-5-carboxylic acid
IUPAC Name3-(((tert-Butoxycarbonyl)amino)methyl)-1,2,4-oxadiazole-5-carboxylic acid
Molecular FormulaC9H13N3O5
Molecular Weight243.22
SMILESO=C(C1=NC(CNC(OC(C)(C)C)=O)=NO1)O
InChI KeyLTXVBZXSDDGVBB-UHFFFAOYSA-N
Synonym3-[[[(tert-Butoxy)carbonyl]amino]methyl]-1,2,4-oxadiazole-5-carboxylic acid;3-((tert-butoxycarbonyl)methyl)-1,2,4-oxadiazole-5-carboxylic acid;3-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]-1,2,4-oxadiazole-5-carboxylic acid;1,2,4-Oxadiazole-5-carboxylic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-
CAS No.946667-81-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACBYPB231 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBYPB231 route product structure diagram
    ACBYPB231946667-81-8
Inquiry

2. ACBYPB231 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBYPB231 route product structure diagram
    ACBYPB231946667-81-8
Inquiry

Comments (0)